ODT - オドネイト・セラピュ―ティクス （Odonate Therapeutics Inc.）

Odonate Therapeutics Inc (ODT) shares closed today 16.8% lower than it did at the end of yesterday. The stock is currently down 19.3% year-to-date, down 94.5% over the past 12 months, and down 95.3% over the past five years. Today, the Dow Jones Industrial Average fell 0.0%, and the S&P 500 fell 0.4%. Trading Activity Shares traded as high as $1.56 and as low as $0.85 this week.Shares closed 96.2% below its 52-week high and 28.2% above its 52-week low.Trading volume this week was 89.0% lower than the 10-day average and 86.2% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.3. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price lags the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price lags the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis The company share price lags the performance of its peers in the Health Care industry sector today, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -1296.8% The company's stock price performance over the past 12 months lags the peer average by 14859.9% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.

Odonate Therapeutics Inc (ODT) shares closed today at 0.8% above its 52 week low of $1.30, giving the company a market cap of $50M. The stock is currently down 3.0% year-to-date, down 93.1% over the past 12 months, and down 94.3% over the past five years. This week, the Dow Jones Industrial Average fell 0.5%, and the S&P 500 fell 1.7%. Trading Activity Trading volume this week was 61.2% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.3. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -655.2% The company's stock price performance over the past 12 months lags the peer average by 5661.3% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.

SAN DIEGO, Dec. 22, 2021 (GLOBE NEWSWIRE) -- National law firm Morris Kandinov is investigating the actions of the officers and board of directors of Corcept Therapeutics, Inc., Match Group, Inc., Inc., loanDepot, Inc., and Odonate Therapeutics, Inc. If you are a current owner of shares of any of these stocks, contact leo@moka.law or call (619) 780-3993.

Odonate Therapeutics, Inc. (NASDAQ:ODT) was the target of a large growth in short interest in November. As of November 30th, there was short interest totalling 513,400 shares, a growth of 85.0% from the November 15th total of 277,500 shares. Based on an average trading volume of 604,900 shares, the short-interest ratio is currently 0.8 days. []

Odonate Therapeutics, Inc. (NASDAQ:ODT) major shareholder Ecor1 Capital, Llc purchased 185,941 shares of the companys stock in a transaction dated Wednesday, December 1st. The stock was purchased at an average price of $1.66 per share, for a total transaction of $308,662.06. The transaction was disclosed in a document filed with the Securities & Exchange Commission, []